Exane Derivatives’s McKesson MCK Stock Holding History
Bought
Maintained
Sold
Other funds holding MCK
Exane Derivatives's MCK Position: Q2 2022 in Review
Exane Derivatives sold out of McKesson (MCK) in Q2 2022, closing a stake of 1,744 shares — an estimated $534K sold.
Exane Derivatives first reported a position in MCK in Q3 2015 and held it in 27 quarters. The position peaked at $17.4M in Q3 2015. 1,168 funds tracked by Wall St. Rank hold MCK as of Q2 2022.
- Exane Derivatives reported no remaining McKesson position as of Q2 2022 after selling out during the quarter.
- Exane Derivatives sold 1,744 McKesson shares in Q2 2022, an estimated $534K.
- Exane Derivatives first reported a position in McKesson in Q3 2015 and held it in 27 quarters.
- Exane Derivatives's McKesson position peaked at $17.4M in Q3 2015.
- 1,168 funds tracked by Wall St. Rank held McKesson as of Q2 2022.
Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.